Pre-Tax Profit Margin: Earnings before taxes as a portion of total revenue. Calculated as: Pre-Tax Income / Total Revenues
Atara Biotherapeutics, Inc. (ATRA) had Pre-Tax Profit Margin of 27.09% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$120.77M |
|
$32.69M |
|
$21.21M |
|
$99.56M |
|
$84.91M |
|
$35.86M |
|
$-3.14M |
|
$32.72M |
|
$32.72M |
|
$32.69M |
|
$32.69M |
|
$32.69M |
|
$32.69M |
|
$35.86M |
|
$38.24M |
|
12.54M |
|
12.72M |
|
$2.61 |
|
$2.57 |
|
| Balance Sheet Financials | |
$12.21M |
|
$0.07M |
|
$8.02M |
|
$20.23M |
|
$14.92M |
|
-- |
|
$43.81M |
|
$58.74M |
|
$-38.50M |
|
$-38.50M |
|
$-38.50M |
|
7.32M |
|
| Cash Flow Statement Financials | |
$-50.94M |
|
$18.15M |
|
$16.10M |
|
$25.18M |
|
$8.48M |
|
$-16.69M |
|
$9.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.82 |
|
-- |
|
-- |
|
-- |
|
-- |
|
82.44% |
|
29.69% |
|
29.69% |
|
31.66% |
|
|
Pre-Tax Profit Margin |
27.09% |
27.07% |
|
$-49.99M |
|
-- |
|
-- |
|
-- |
|
5.97 |
|
-- |
|
96.39 |
|
3.79 |
|
-84.90% |
|
-84.90% |
|
161.54% |
|
-84.90% |
|
$-5.26 |
|
$-3.93 |
|
$-4.01 |
|